
Opinion|Videos|October 28, 2023
Role of CAR-T Therapy in R/R Follicular Lymphoma
An overview of the evolving role of CAR-T therapy in patients with relapsed or refractory follicular lymphoma.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
3
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
4
What Does an End-of-Life Doula Do for Patients With Cancer?
5





!["I can’t make [treatment] decisions for you, but I can give you realistic expectations," said Herbert Lepor, MD, of NYU Langone Health.](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/11e93c561a9ff98f731b152d7f48e6f792831864-1000x1000.jpg?w=350&fit=crop&auto=format)



















































